Fenyramidol
Small moleculeexperimental
Clinical trial activity
1 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jun 26, 2019 (NCT04639869)
Timeline
2010s
- Jan 1, 2019
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04639869 | Phase 1 | Jun 26, 2019 | Farmagen Ar-Ge Biyot. Ltd. Sti, Novagenix Bioanalytical Drug R&D Center, Pharmactive İlaç San.ve Tic.A.S, RS Arastirma Egitim Danismanlik Ilac Sanayi Ticaret A.S. |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Farmagen Ar-Ge Biyot. Ltd. Sti | For profit | 1 | 0 | 1 | 2019 |
| Novagenix Bioanalytical Drug R&D Center | For profit | 1 | 0 | 1 | 2019 |
| Pharmactive İlaç San.ve Tic.A.S | For profit | 1 | 0 | 1 | 2019 |
| RS Arastirma Egitim Danismanlik Ilac Sanayi Ticaret A.S. | For profit | 1 | 1 | 1 | 2019 |
4 organizations
Page 1 / 1